European Union ►

Eisai's Leqembi targets significant growth in China as Alzheimer's diagnosis methods evolve. (Photo: Eisai Pharma)

2 min read

Eisai’s Alzheimer’s drug Leqembi set for China rollout

Post Date 02/05/2024

Eisai plans to introduce its groundbreaking Alzheimer’s drug, Leqembi, to 1,500 people in China this year, with expectations of significant growth in 2025 as diagnosis [more…]

Popular nasal decongestant tablets, including Actifed Rhume and Humex, may pose risk of heart attacks and strokes, ANSM cautions. (Photo: MaxPPP)

3 min read

European Union France Health & Fitness

ANSM warns of health risks surrounding popular nasal decongestants

Post Date 10/23/2023

In a recent announcement, the French National Medicines Safety Agency (ANSM) has raised concerns about the use of oral vasoconstrictor medications commonly used to relieve [more…]